<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Nutr Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Nutr Sci</journal-id><journal-id journal-id-type="publisher-id">JNS</journal-id><journal-title-group><journal-title>Journal of Nutritional Science</journal-title></journal-title-group><issn pub-type="epub">2048-6790</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26090092</article-id><article-id pub-id-type="pmc">4463010</article-id><article-id pub-id-type="doi">10.1017/jns.2014.68</article-id><article-id pub-id-type="pii">S2048679014000688</article-id><article-id pub-id-type="publisher-id">00068</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A randomised, double- blind, cross-over study investigating the prebiotic
effect of agave fructans in healthy human subjects</article-title><alt-title alt-title-type="left-running">P. Ramnani <italic>et al.</italic></alt-title><alt-title alt-title-type="right-running">A randomised, double- blind, cross-over study
investigating the prebiotic effect of agave fructans in healthy human subjects</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ramnani</surname><given-names>P.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Costabile</surname><given-names>A.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bustillo</surname><given-names>A. G. R.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Gibson</surname><given-names>G. R.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Food and Nutritional
Sciences</addr-line>, <institution>University of Reading</institution>, <addr-line>Reading
RG6 6AP</addr-line>, <country>UK</country></aff><aff id="aff2"><label>2</label><addr-line>Bustar Alimentos</addr-line>, <addr-line>SAPI de
CV</addr-line>, <addr-line>Efrain Gonzalez Luna 2503</addr-line>, <addr-line>Col Arcos Sur,
44130 Guadalajara</addr-line>, <addr-line>Jalisco</addr-line>, <country>Mexico</country></aff><author-notes><corresp id="cor1"><label>*</label><addr-line><bold>Corresponding author:</bold> P.
Ramnani</addr-line>, email <email>p.ramnani@rdg.ac.uk</email>; <email>priyaramnani@rediffmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>13</day><month>3</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e10</elocation-id><history><date date-type="received"><day>15</day><month>2</month><year>2014</year></date><date date-type="rev-recd"><day>31</day><month>5</month><year>2014</year></date><date date-type="accepted"><day>11</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access"><license-p><!--CREATIVE COMMONS-->The online version of this article is published within an Open Access
environment subject to the conditions of the Creative Commons Attribution license
&#x0003c;<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S2048679014000688a.pdf"/><abstract abstract-type="normal"><p>This placebo-controlled, randomised, double-blind, cross-over human feeding study aimed
to determine the prebiotic effect of agave fructans. A total of thirty-eight volunteers
completed this trial. The treatment consisted of 3 weeks' supplementation with 5&#x000a0;g/d of
prebiotic agave fructan (Predilife) or equivalent placebo (maltodextrin), followed by a
2-week washout period following which subjects were crossed over to alternate the
treatment arm for 3 weeks followed by a 2-week washout. Faecal samples were collected at
baseline, on the last day of treatment (days 22 and 58) and washout (days 36 and 72),
respectively. Changes in faecal bacterial populations, SCFA and secretory IgA were
assessed using fluorescent <italic>in situ</italic> hybridisation, GC and ELISA,
respectively. Bowel movements, stool consistencies, abdominal comfort and mood changes
were evaluated by a recorded daily questionnaire. In parallel, the effect of agave
fructans on different regions of the colon using a three-stage continuous culture
simulator was studied. Predilife significantly increased faecal bifidobacteria
(log<sub>10</sub> 9&#x000b7;6 (<sc>sd</sc> 0&#x000b7;4)) and lactobacilli (log<sub>10</sub> 7&#x000b7;7
(<sc>sd</sc> 0&#x000b7;8)) compared with placebo (log<sub>10</sub> 9&#x000b7;2 (<sc>sd</sc> 0&#x000b7;4);
<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;00) (log<sub>10</sub> 7&#x000b7;4 (<sc>sd</sc> 0&#x000b7;7); <italic>P</italic>
=&#x000a0;0&#x000b7;000), respectively. No change was observed for other bacterial groups tested, SCFA,
secretory IgA, and PGE<sub>2</sub> concentrations between the treatment and placebo.
Denaturing gradient gel electrophoresis analysis indicated that bacterial communities were
randomly dispersed and no significant differences were observed between Predilife and
placebo treatments. The <italic>in vitro</italic> models showed similar increases in
bifidobacterial and lactobacilli populations to that observed with the <italic>in
vivo</italic> trial. To conclude, agave fructans are well tolerated in healthy human
subjects and increased bifidobacteria and lactobacilli numbers <italic>in vitro</italic>
and <italic>in vivo</italic> but did not influence other products of fermentation.</p></abstract><kwd-group><title>Key words</title><kwd>Agave fructans</kwd><kwd>Gut microbiota</kwd><kwd>Prebiotics</kwd></kwd-group><kwd-group kwd-group-type="abbreviations"><title>Abbreviations</title><kwd>DGGE, denaturing gradient gel
electrophoresis
</kwd><kwd>FISH, fluorescent <italic>in situ</italic>
hybridisation
</kwd><kwd>sIgA, secretory IgA
</kwd><kwd>SS1, steady state 1
</kwd><kwd>SS2, steady state 2
</kwd></kwd-group><counts><fig-count count="2"/><table-count count="7"/><ref-count count="52"/><page-count count="10"/></counts></article-meta></front><body><p>The importance of human gastrointestinal microbiota is becoming increasingly recognised.
Diet&#x02013;microbe interactions within the colon can result in a number of health benefits:
protection from invading pathogens, modulation of immune system, production of vitamins and
removal of carcinogens<sup>(</sup><xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref><sup>&#x02013;</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>)</sup>. Selectively modulating the gut microbial activities is the basis of the
prebiotic concept that advocates targeting beneficial bacteria through non-viable food
ingredients<sup>(</sup><xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref><sup>,</sup><xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref><sup>)</sup>.</p><p>To date most attention has been focused on the prebiotic potential of fructo-oligosaccharides
and <italic>trans</italic>-galacto-oligosaccharides. However, other fibres including resistant
starches or dextrins, glucans, gums and pectins are also increasingly being recognised as
having prebiotic potential<sup>(</sup><xref rid="ref6" ref-type="bibr">
<sup>6</sup>
</xref><sup>,</sup><xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref><sup>)</sup>.</p><p>Fructans have been classified according to their structure and fructosyl linkage as inulin,
levan, graminans, neoseries levan and neoseries graminans<sup>(</sup><xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref><sup>)</sup>. The importance of inulin-type fructans with linear &#x003b2; (2&#x000a0;&#x02192;&#x000a0;1) linkages in
human and bowel health is well established both <italic>in vitro</italic> and <italic>in
vivo</italic><sup>(</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>,</sup><xref rid="ref9" ref-type="bibr">
<sup>9</sup>
</xref><sup>)</sup>. They have been consistently associated with increases in populations of
bifidobacteria and lactobacilli and production of desirable fermentation
endproducts<sup>(</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>,</sup><xref rid="ref10" ref-type="bibr">
<sup>10</sup>
</xref><sup>,</sup><xref rid="ref11" ref-type="bibr">
<sup>11</sup>
</xref><sup>)</sup>. The rate and extent of fermentation of fructans is influenced by the
degree of polymerisation<sup>(</sup><xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref><sup>&#x02013;</sup><xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref><sup>)</sup>. Several studies have investigated linear-chain fructans<sup>(</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>)</sup>; however, there are few data available on branched-chain
fructans<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>)</sup>.</p><p>Agave plants have been historically known to be an important source of natural fibre and
alcoholic beverages in Mexico<sup>(</sup><xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref><sup>)</sup>. Fructans from agave demonstrate wide diversity with a complex and highly
branched mixture of fructo-oligosaccharides and fructans containing both &#x003b2; (2&#x000a0;&#x02192;&#x000a0;1) and &#x003b2;
(2&#x000a0;&#x02192;&#x000a0;6) linkages with internal (neoseries fructans) and external (graminans fructans) glucose
units<sup>(</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>)</sup>. Different agave species show variation in proportion of glucose
polymerisations and &#x003b2; (2&#x000a0;&#x02192;&#x000a0;1) and &#x003b2; (2&#x000a0;&#x02192;&#x000a0;6) linkages<sup>(</sup><xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref><sup>)</sup>. Structural branching of agave fructans may result in altered gut
bacterial modulation and fermentation profile compared with inulin-type fructans. Scanty
information on the prebiotic properties of agave fructans justifies the present study where
fructans from <italic>Agave tequilana</italic> Weber var. <italic>azul.</italic> (Predilife)
were tested in an <italic>in vitro</italic> gut model and human trial. A randomised,
placebo-controlled, cross-over design was chosen due to its robustness and reduced
intra-individual variability.</p><p>Fermentation of prebiotics is primarily anaerobic and thus leads to the production of SCFA.
The structure of carbohydrates and gut microflora influence SCFA profiles<sup>(</sup><xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref><sup>,</sup><xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref><sup>)</sup>. Therefore, in addition to studying the effect of agave fructans on the
composition of gut microbiota, SCFA concentrations were also measured.</p><p>The prebiotic modulation of bacterial communities has been shown to influence the host immune
functions, including up-regulation of immunoglobulins and reduction in
prostaglandins<sup>(</sup><xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref><sup>,</sup><xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref><sup>)</sup>. Consequently, the present study determined levels of the two biomarkers:
secretory IgA (sIgA) and PGE<sub>2</sub>.</p><sec sec-type="materials|methods" id="sec1"><title>Materials and methods</title><sec id="sec1-1"><title>Test products</title><p>The prebiotic was provided to volunteers as sachets containing 5&#x000a0;g Predilife, a purified
powder extracted from <italic>Agave tequilana</italic> Weber var. <italic>azul.</italic>
The preparation of Predilife has been described previously<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>)</sup>. The placebo was a sachet containing 5&#x000a0;g of commercially available
Maltodextrin Star DRI&#x000ae; 10 with Dextrose Equivalent 10 (Tate and Lyle). All test and
placebo products were packaged and blinded by Bustar Alimentos, Mexico. The products were
only distinguishable by the colour of the label. The nutritional information of the
products is given in <xref ref-type="table" rid="tab01">Table 1</xref>. <table-wrap id="tab01" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Nutritional information of placebo and Predilife</p></caption><alternatives><graphic xlink:href="S2048679014000688_tab1"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1">Nutrients (per 5&#x000a0;g dose)</th><th align="center" rowspan="1" colspan="1">Placebo*</th><th align="center" rowspan="1" colspan="1">Predilife&#x02020;</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Energy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;kJ</td><td rowspan="1" colspan="1">66&#x000b7;32</td><td rowspan="1" colspan="1">34&#x000b7;12</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;kcal</td><td rowspan="1" colspan="1">15&#x000b7;6</td><td rowspan="1" colspan="1">8&#x000b7;15</td></tr><tr><td rowspan="1" colspan="1">Protein (g)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">Trace</td></tr><tr><td rowspan="1" colspan="1">Carbohydrates (g)</td><td rowspan="1" colspan="1">3&#x000b7;90</td><td rowspan="1" colspan="1">4&#x000b7;90</td></tr><tr><td rowspan="1" colspan="1">Sugars (g)</td><td rowspan="1" colspan="1">0&#x000b7;78</td><td rowspan="1" colspan="1">0&#x000b7;20</td></tr><tr><td rowspan="1" colspan="1">Fat (g)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">Trace</td></tr><tr><td rowspan="1" colspan="1">SFA (g)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Cholesterol (mg)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Dietary fibre (g)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">4&#x000b7;70</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Of which fructans (inulin) (g)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">4&#x000b7;70</td></tr><tr><td rowspan="1" colspan="1">Na (mg)</td><td rowspan="1" colspan="1">8&#x000b7;59</td><td rowspan="1" colspan="1">2&#x000b7;50</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>* Placebo ingredients: Maltodextrin Star DRI 10, orange flavour, orange colour,
sucralose.</p></fn><fn><p>&#x02020; Predilife ingredients: Predilife agave fructans, orange flavour, orange colour,
sucralose.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec1-2"><title>Study design</title><p>The dietary intervention study was a double-blind, randomised, placebo-controlled
cross-over trial. At 14 d before the start of the study, volunteers were asked to follow a
restricted diet; no consumption of pre- or probiotics was allowed. A total of thirty-eight
subjects were randomly allocated into one of the two groups using an automated
randomisation sequence generated by a web-based tool (randomisation.com). The first group
(<italic>n</italic> 19) consumed Predilife (5&#x000a0;g/d) for 3 weeks followed by a washout
period for 2 weeks; they then consumed an equivalent placebo (5&#x000a0;g/d) for 3 weeks followed
by a 2-week washout period. The second group (<italic>n</italic> 19) received a placebo
for the first 3 weeks followed by a 2-week washout period, Predilife for 3-weeks followed
by a 2-week washout (<xref ref-type="fig" rid="fig01">Fig. 1</xref>). No trial product was
consumed during the 2-week washout period. During the intervention period, study subjects
were instructed to consume one sachet of the provided treatment by mixing the test powder
in 300&#x000a0;ml of water with breakfast every day. During the trial, volunteers and researchers
were unaware which product was taken by which participant. <fig id="fig01" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>Study design.</p></caption><graphic xlink:href="S2048679014000688_fig1"/></fig></p></sec><sec id="sec1-3" sec-type="subjects"><title>Subjects</title><p>A total of forty healthy human volunteers were recruited from the Reading area of the UK
to participate in the present study. The subjects were recruited by advertising on notice
boards and emails were sent to all staff at Reading University. In addition, letters were
sent to volunteers registered with the Sensory Dimensions (Reading, UK) database. Two
volunteers were prescribed antibiotics and were thus excluded from the study, before the
first and the second feeding period, respectively. For analysis purposes, thirty-eight
volunteers, nineteen males and nineteen females were included. Their mean age was 35
(<sc>sd</sc> 8&#x000b7;0) years and average BMI was 24&#x000b7;1 (<sc>sd</sc> 3&#x000b7;0) kg/m<sup>2</sup>.
Written informed consent was obtained from all subjects. The study was reviewed and
approved by the University of Reading Ethics Committee. The study protocol was conducted
according to guidelines in the Declaration of Helsinki.</p></sec><sec id="sec1-4"><title>Inclusion and exclusion criteria</title><sec id="sec1-4-1"><title>Inclusion criteria</title><p>Inclusion criteria were a signed consent form, aged 18&#x02013;50 years inclusive, BMI
18&#x02013;30&#x000a0;kg/m<sup>2</sup> inclusive, non-smoking and good general health.</p></sec><sec id="sec1-4-2"><title>Exclusion criteria</title><p>Volunteers were excluded from the trial if there was evidence of physical or mental
disease or major surgery. Volunteers with a history of drug or alcohol abuse, severe
allergy, abnormal drug reaction, pregnant, lactating or planning pregnancy were excluded
from the study. Intake of an experimental drug within 4 weeks before the study, former
participation in a probiotics, prebiotics or laxative trial within the previous 3
months, use of antibiotics within the previous 6 months, chronic constipation or other
chronic gastrointestinal complaints (for example, irritable bowel syndrome) were all
exclusion criteria.</p></sec></sec><sec id="sec1-5"><title>Diet and medication requirements during the trial</title><p>Intake of prebiotics, probiotics and drugs active on gastrointestinal motility,
antibiotic treatment or any class of laxatives were not permitted. Subjects were not
allowed to participate in any other nutritional or pharmaceutical trials during the study.
Any medication taken was recorded in volunteer diaries. Volunteers were instructed not to
alter their usual diet or fluid intake during the study.</p></sec><sec id="sec1-6"><title>Volunteer diaries</title><p>Volunteers were asked to keep diaries throughout the study to record stool frequency and
consistency, abdominal pain, intestinal bloating and flatulence on a daily basis.
Energetic status, happiness, alertness and stress levels as compared with normal were also
recorded. Any concomitant medication, adverse events and failure to consume any treatments
were also recorded by the volunteers.</p><p>In addition, volunteers were asked to record the time of consumption of the product for
measuring compliance. Volunteers were instructed to return any unused sachets at the end
of the intervention. They were considered compliant for the product if they consumed at
least 90 % of the product over the 3-week intervention. They were also asked not to alter
their usual diet and fluid intake and record changes, if any.</p></sec><sec id="sec1-7"><title>Stool sample collection and processing</title><p>Freshly voided stool samples collected in plastic pots were stored in an anaerobic
cabinet (10 % H<sub>2</sub>, 10 % CO<sub>2</sub>, 80 % N<sub>2</sub>; Don Whitley
Scientific) at 37&#x000b0;C and processed within 2&#x000a0;h of voiding. Faecal samples were collected
before and after treatment with either agave fructan or maltodextrin and washout on days
0, 22, 36, 58 and 72 (<xref ref-type="fig" rid="fig01">Fig. 1</xref>). Samples were
diluted 1:10 (w/w) in PBS (0&#x000b7;1 <sc>m</sc>, pH 7&#x000b7;0) and homogenised in a stomacher (Seward)
at normal speed for 2&#x000a0;min. The faecal slurry was transferred to 50&#x000a0;ml sterile plastic
centrifuge tubes containing 2&#x000a0;g glass beads (diameter 5&#x000a0;mm) and vortexed for 30 s. Samples
were then centrifuged at 400 <bold><italic>g</italic></bold> for 5&#x000a0;min at room temperature and supernatant fractions processed for fluorescent
<italic>in situ</italic> hybridisation (FISH) and SCFA analysis. The pellet was
resuspended in 500&#x000a0;&#x000b5;l of autoclaved PBS&#x02013;glycerol (1:1) for DNA extraction. A quantity of
1&#x000a0;g of faeces was collected in microcentrifuge tubes and stored at &#x02013;20&#x000b0;C for ELISA.</p></sec><sec id="sec1-8"><title>Fluorescent <italic>in situ</italic> hybridisation</title><p>Synthetic oligonucleotide probes targeting specific regions of the 16S rRNA labelled with
fluorescent Cy 3 were utilised for enumeration of bacterial populations. The faecal
supernatant fractions obtained as described above were fixed in 4 % (w/v) paraformaldehyde
and hybridised with appropriate probes as described by Vulevic <italic>et
al.</italic><sup>(</sup><xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref><sup>)</sup>. The probes used were Bif164<sup>(</sup><xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref><sup>)</sup>, Lab158<sup>(</sup><xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref><sup>)</sup>, Erec482<sup>(</sup><xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref><sup>)</sup>, Ato291<sup>(</sup><xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref><sup>)</sup>, Bac303<sup>(</sup><xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref><sup>)</sup>, Rrec584<sup>(</sup><xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref><sup>)</sup>, Eco1531<sup>(</sup><xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref><sup>)</sup> and Eub338 mix<sup>(</sup><xref rid="ref26" ref-type="bibr">
<sup>26</sup>
</xref><sup>)</sup> specific for bifidobacteria,
<italic>Lactobacillus</italic>/<italic>Enterococcus</italic> spp.,
<italic>Eubacterium</italic>/<italic>Clostridium coccoides</italic> group,
<italic>Atopobium</italic> spp., <italic>Bacteroides</italic>,
<italic>Roseburia</italic>/<italic>Eubacterium rectale</italic> spp.,
<italic>Escherichia coli</italic> and total bacteria, respectively. Slides were examined
under an epifluorescence microscope (Eclipse 400; Nikon) using the Fluor 100 lens. At
least fifteen random fields of view were counted for each well and microbial counts
expressed as log <sub>10</sub> bacterial cells per g dry weight faeces.</p></sec><sec id="sec1-9"><title>SCFA analyses</title><p>Fermentation output was determined by measuring changes in faecal SCFA concentrations in
the collected supernatant fractions. Acetate, propionate, butyrate, isobutyrate, valerate,
isovalerate and caproate were analysed in the collected samples as their salyl derivatives
by GC<sup>(</sup><xref rid="ref27" ref-type="bibr">
<sup>27</sup>
</xref><sup>)</sup>. The organic acids were extracted by addition of 0&#x000b7;5&#x000a0;ml concentrated
hydrochloric acid and 2&#x000a0;ml diethyl ether.
<italic>N</italic>-tert-butyldimethylsilyl-<italic>N</italic>-methyltrifluoroacetamide
(MTBSTFA) was used to derivatise the samples at 80&#x000b0;C for 20&#x000a0;min. Samples were then run
through a 5890 series II GC system (Hewlett Packard) fitted with a SGE-HT5
(0&#x000b7;32&#x000a0;mm&#x000a0;&#x000d7;&#x000a0;25&#x000a0;m&#x000a0;&#x000d7;&#x000a0;0&#x000b7;1&#x000a0;&#x000b5;m) (J &#x00026; W Scientific) and a flame ionisation detector.
Injector, oven and detector were set at 275, 250 and 275&#x000b0;C, respectively. A quantity of
1&#x000a0;&#x000b5;l of each sample was injected with a run time of 10&#x000a0;min. Peaks were integrated using
the Atlas Lab managing software (Thermo Lab Systems). Fatty acid concentrations were
calculated in mmol/l by comparing their peak areas with standards.</p></sec><sec id="sec1-10"><title>Immunological analysis</title><p>Faecal sIgA (Oxford Biosystems) and PGE<sub>2</sub> (Neogen Corp.) were measured by ELISA
using commercially available kits and instructions provided by the manufacturers.
Absorption was measured using an ELISA reader (GENios; Tecan). A calibration curve was
constructed using a range of standards which were then used to assay the immunological
marker in each of the samples. The results were expressed as &#x000b5;g/g or pg/g faeces (wet
weight).</p></sec><sec id="sec1-11"><title>Bacterial DNA extraction and PCR&#x02013;denaturing gradient gel electrophoresis</title><p>Bacterial cell pellets collected after centrifugation and resuspension in PBS&#x02013;glycerol,
frozen at &#x02013;20&#x000b0;C, were thawed on ice. Bacterial DNA was extracted using the FastDNA Spin
kit (Qbiogene) according to the manufacturer's instructions. DNA was resuspended in 50&#x000a0;&#x000b5;l
of sterile water, quantified using a NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies) and stored at &#x02013;20&#x000b0;C. PCR using universal P2 and P3 primers was performed as
previously reported<sup>(</sup><xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref><sup>)</sup>. Approximately 5&#x000a0;&#x000b5;l of each PCR product were applied to denaturing
gradient gel electrophoresis (DGGE) using a VWR CTV400-DGGE unit (VWR International). The
polyacrylamide gel (acrylamide-bisacrylamide, 37&#x000b7;5:1; Bio-Rad) had a linear denaturing
gradient of 30&#x02013;70 %. Electrophoresis was run in 0&#x000b7;5&#x000d7; Tris acetate EDTA (TAE) buffer (made
from 50&#x000d7; concentrate; Fischer) at 100&#x000a0;V and 60&#x000b0;C for 16&#x000a0;h. Gels were silver stained and
scanned using a Cannon scanner (Lide 50; Cannon) and analysed using FPQuest Software
version 4&#x000b7;5 (Bio-Rad). In order to compensate for gel-to-gel differences and distortion
due to electrophoresis, DGGE patterns were aligned and normalised using a reference ladder
composed of baseline sample from one volunteer. After normalisation, bands from each
sample were defined using appropriate densitometric curves. Bands constituting less than 1
% of the total band area were omitted from further analysis. Similarity between DGGE
profiles was calculated using the Pearson correlation. Clustering of profiles was done
using the unweighted pair-group method using arithmetic average.</p></sec><sec id="sec1-12"><title>Three-stage continuous culture model</title><p>Parallel to the human study, <italic>in vitro</italic> testing was carried out using a
three-stage continuous culture model of the human colon<sup>(</sup><xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref><sup>)</sup>. The model consisted of three glass vessels with increasing working
volume aligned in series. The first vessel simulated the proximal colon and had an
operating volume of 280&#x000a0;ml and was fed with the growth medium. The second vessel,
simulating the transverse colon, had an operating volume of 300&#x000a0;ml and was fed from the
overflow of the first vessel. The third vessel simulating the distal colon had an
operating volume of 320&#x000a0;ml and was fed from the overflow of the second vessel. Culture
fluid from the third vessel was vented into a waste container. All vessels were
continuously stirred and maintained at 37&#x000b0;C by a circulating water jacket. The pH of the
vessels was maintained at 5&#x000b7;4, 6&#x000b7;2 and 6&#x000b7;7 for vessels 1, 2 and 3, respectively, by using
pH controllers (Electrolab) pumping in 0&#x000b7;5 <sc>m</sc>-HCl/NaOH solutions as required. The
system was kept anaerobic by continuously sparging with O<sub>2</sub>-free N<sub>2</sub>
through the liquid (about 15&#x000a0;ml/min) in all vessels. The culture medium consisted of the
following components (g/l): starch 5; peptone water 5; yeast extract 4&#x000b7;5; tryptone 5; NaCl
4&#x000b7;5; KCl 4&#x000b7;5; mucin 4; casein 3; pectin 2; xylan 2; arabinogalactan 2; NaHCO<sub>3</sub>
1&#x000b7;5; MgSO<sub>4</sub>.7H<sub>2</sub>O 1&#x000b7;25; guar gum 1; inulin 1; cysteine HCl 0&#x000b7;8;
KH<sub>2</sub>PO<sub>4</sub> 0&#x000b7;5; K<sub>2</sub>HPO<sub>4</sub> 0&#x000b7;5; bile salts no. 3
0&#x000b7;4; CaCl<sub>2</sub>.6H<sub>2</sub>O 0&#x000b7;15; haemin 0&#x000b7;05; vitamin K 0&#x000b7;01;
FeSO<sub>4</sub>.7H<sub>2</sub>O 0&#x000b7;005; Tween 80 1&#x000a0;ml. A quantity of 4&#x000a0;ml rezarsurin was
added at a concentration of 0&#x000b7;025 % (w/v) to the medium as an indicator of anaerobicity.</p><p>Faecal inoculum was collected from one healthy human volunteer, aged 22 years, who had
not taken antibiotics 6 months before sample collection. The sample was diluted 1:5 (w/v)
in PBS (0&#x000b7;1 <sc>m</sc>; pH 7&#x000b7;4) and homogenised in a stomacher (Seward) for 2&#x000a0;min. Each
vessel was inoculated with 100&#x000a0;ml fresh faecal slurry. After 24&#x000a0;h of inoculation, the
medium flow was initiated and the system ran for eight full volume turnovers (16 d) to
allow steady state 1 (SS1) to be achieved. At SS1, 5&#x000a0;ml samples were collected from each
vessel for three consecutive days and centrifuged at 13 000 <bold><italic>g</italic></bold> for 10&#x000a0;min. The supernatant fractions were fixed in 4 % (w/v) paraformaldehyde for
FISH analysis. For SCFA analysis the supernatant fractions were stored at &#x02013;20&#x000b0;C and
analysed by GC. Total bacterial counts and SCFA concentrations were analysed over three
consecutive days to confirm SS1. Three gut models were run using faecal samples from the
same donor, namely Synergy 1 (a prebiotic &#x02013; fructo-oligosaccharide inulin mix from
Orafti), Predilife and maltodextrin. After SS1, each of the test products was added to the
first vessel in 5&#x000a0;g doses each day until steady state 2 (SS2) was reached after further
eight volume turnovers (33 d). Samples were obtained as above for measuring any changes in
gut microbiota using FISH and SCFA analysis for three consecutive days until a second
steady state (SS2) was established.</p></sec><sec id="sec1-13"><title>Statistical analyses</title><p>A total of forty healthy human volunteers were recruited based on statistical power
calculation. The sample size was determined to detect a 0&#x000b7;5&#x000a0;log<sub>10</sub> change in
bifidobacterial counts with power set at 0&#x000b7;9, and a significance level of 0&#x000b7;05 based on
our previous prebiotic studies in human volunteers conducted with the same microbiological
techniques<sup>(</sup><xref rid="ref30" ref-type="bibr">
<sup>30</sup>
</xref><sup>,</sup><xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref><sup>)</sup>.</p><p>Statistical analysis was performed on bacterial counts (log<sub>10</sub> cells/g faeces)
and fermentation characteristics using SPSS software (version 19; SPSS Inc.). Data from
volunteers that completed the intervention were included in the analysis. Statistical
significance of the overall treatment effect was judged using linear mixed models with
compound symmetry repeated covariance format. Treatment, period and sequence were fixed
effects, period was a repeated measure and participant was a random effect. All models
were adjusted for age, sex, BMI, baseline values, sequence and period. Treatment, sequence
and period terms were used to test for the presence of a carryover effect. In exploratory
terms, there were no significant period order effects noted. The effects of age, sex or
BMI on treatment were assessed in each model by inserting an interaction between treatment
and each of the terms one at a time. Stratified analyses were performed if either of the
interactions was significant. Student's <italic>t</italic> tests were used to compare the
pre-treatment and post-treatment period measurements within each treatment, bowel habits,
gastrointestinal symptoms and mood data. Data for DGGE were analysed by using FPQuest
Software version 4&#x000b7;5 (Bio-Rad). For all analyses, <italic>P</italic> &#x0003c;&#x000a0;0&#x000b7;05
indicated statistical significance.</p></sec></sec><sec sec-type="results" id="sec2"><title>Results</title><sec id="sec2-1"><title>Subject characteristics and compliance</title><p>In total, forty volunteers entered the cross-over study (twenty female, twenty males); of
these, two were excluded due to antibiotic intake. Therefore, a total of thirty-eight
volunteers (nineteen female, nineteen males) aged 20&#x02013;49 years (average age 35 (<sc>sd</sc>
8&#x000b7;0) years) with average BMI 24&#x000b7;1 (<sc>sd</sc> 3&#x000b7;0) kg/m<sup>2</sup> completed the human
trial. Compliance for product intake, as assessed by diary data of regular consumption of
sachets and returned unused sachets, was good (95&#x02013;100 %). None of the volunteers indicated
alterations in diet or fluid intake and were thus complaint.</p></sec><sec id="sec2-2"><title>Medication and adverse events</title><p>Volunteers had consumed a variety of over-the-counter drugs such as cold and flu
remedies, anti-allergy tablets and painkillers. No extremes were observed and the level of
medication was judged as representative of a typical UK population.</p><p>Among adverse events recorded in volunteer diaries, headache, cough and colds, fever,
backache, toothache were recorded over the two treatment and washout periods. No serious
adverse events were recorded.</p></sec><sec id="sec2-3"><title>Faecal microbiota</title><p>Changes in bacterial numbers are shown in <xref ref-type="table" rid="tab02">Table
2</xref>. Consumption of Predilife increased bifidobacterial numbers (log<sub>10</sub> 9&#x000b7;6
(<sc>sd</sc> 0&#x000b7;4)) compared with placebo (log<sub>10</sub> 9&#x000b7;2 (<sc>sd</sc> 0&#x000b7;4)).
Levels of bifidobacteria returned to approximate baseline levels (log<sub>10</sub> 9&#x000b7;2
(<sc>sd</sc> 0&#x000b7;2)) (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;001) 2 weeks after intervention was
stopped. <table-wrap id="tab02" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Faecal bacterial numbers (log<sub>10</sub> cells/g faeces) determined in
thirty-eight volunteers by fluorescence <italic>in situ</italic> hybridisation in
the placebo-controlled, double-blind, cross-over human feeding study investigating
the effects of Predilife (5&#x000a0;g/d) as compared with the placebo maltodextrin (5&#x000a0;g/d)</p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679014000688_tab2"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="4" rowspan="1">Predilife</th><th align="center" colspan="4" rowspan="1">Maltodextrin</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Baseline</th><th align="center" colspan="2" rowspan="1">Treatment</th><th align="center" colspan="2" rowspan="1">Baseline</th><th align="center" colspan="2" rowspan="1">Treatment</th></tr><tr><th align="left" rowspan="1" colspan="1">Bacterial group</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Total bacteria</td><td rowspan="1" colspan="1">10&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">10&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">10&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">10&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;2</td></tr><tr><td rowspan="1" colspan="1">
<italic>Atopobium</italic>
</td><td rowspan="1" colspan="1">9&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;4</td><td rowspan="1" colspan="1">9&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;4</td><td rowspan="1" colspan="1">9&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">9&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">
<italic>Bacteroides</italic>
</td><td rowspan="1" colspan="1">9&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">9&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">9&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">9&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"><italic>Bifidobacterium</italic> spp.</td><td rowspan="1" colspan="1">9&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;4</td><td rowspan="1" colspan="1">9&#x000b7;6***&#x02020;&#x02020;</td><td rowspan="1" colspan="1">0&#x000b7;4</td><td rowspan="1" colspan="1">9&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">9&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1"><italic>Eubacterium
rectale</italic>/<italic>Clostridium coccoides</italic></td><td rowspan="1" colspan="1">10&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">10&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">10&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">10&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1"><italic>Clostridium histolyticum</italic> group</td><td rowspan="1" colspan="1">7&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">7&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">7&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">7&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1"><italic>Lactobacillus</italic>/<italic>Enterococcus</italic> spp.</td><td rowspan="1" colspan="1">7&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;6</td><td rowspan="1" colspan="1">7&#x000b7;7***&#x02020;&#x02020;&#x02020;</td><td rowspan="1" colspan="1">0&#x000b7;8</td><td rowspan="1" colspan="1">7&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;6</td><td rowspan="1" colspan="1">7&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;6</td></tr><tr><td rowspan="1" colspan="1">
<italic>Escherichia coli</italic>
</td><td rowspan="1" colspan="1">7&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">7&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">7&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">7&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1"><italic>Roseburia</italic>/<italic>Eubacteria</italic> group</td><td rowspan="1" colspan="1">9&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">9&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">9&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">9&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;2</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>*** Mean value was significantly different from that for maltodextrin
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;001).</p></fn><fn><p>Mean value was significantly different from that at baseline: &#x02020;&#x02020;
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;01, &#x02020;&#x02020;&#x02020; <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;001.</p></fn></table-wrap-foot></table-wrap></p><p>Lactobacilli/enterococci numbers also significantly increased following Predilife
treatment (log<sub>10</sub> 7&#x000b7;7 (<sc>sd</sc> 0&#x000b7;8)) as compared with placebo
(log<sub>10</sub> 7&#x000b7;6 (<sc>sd</sc> 0&#x000b7;6)) (<xref ref-type="table" rid="tab02">Table
2</xref>).</p><p>For all the other groups enumerated, no significant differences were observed.</p></sec><sec id="sec2-4"><title>Analysis of bowel habits, intestinal comfort and mood</title><p><xref ref-type="table" rid="tab03">Table 3</xref> summarises data on bowel habits,
intestinal comfort and mood. No significant differences were recorded in the mean daily
stool frequencies and consistencies with either treatment. However, some volunteers did
report a borderline significant trend for more formed stools and decrease in constipation
after consumption of Predilife (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;08). No significant change in
abdominal pain was observed. Predilife consumption led to increased intestinal bloating
(mild to moderate) compared with maltodextrin (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05). No
significant increase in flatulence was observed after consumption of Predilife compared
with placebo. In addition, no significant differences in mood scores were observed with
either treatment. <table-wrap id="tab03" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Summary of bowel habit, intestinal comfort and general mood data recorded on a
daily basis in volunteer diaries throughout the study&#x02021;</p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679014000688_tab3"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="4" rowspan="1">Predilife</th><th align="center" colspan="4" rowspan="1">Maltodextrin</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Baseline</th><th align="center" colspan="2" rowspan="1">Treatment</th><th align="center" colspan="2" rowspan="1">Baseline</th><th align="center" colspan="2" rowspan="1">Treatment</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Stool frequency (<italic>n</italic>/d)</td><td rowspan="1" colspan="1">1&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;4</td><td rowspan="1" colspan="1">1&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;5</td><td rowspan="1" colspan="1">1&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">1&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">Stool consistency</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;Hard</td><td rowspan="1" colspan="1">6&#x000b7;9</td><td rowspan="1" colspan="1">15&#x000b7;2</td><td rowspan="1" colspan="1">6&#x000b7;6</td><td rowspan="1" colspan="1">11&#x000b7;6</td><td rowspan="1" colspan="1">7&#x000b7;3</td><td rowspan="1" colspan="1">11&#x000b7;4</td><td rowspan="1" colspan="1">7&#x000b7;9</td><td rowspan="1" colspan="1">17&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Formed</td><td rowspan="1" colspan="1">73&#x000b7;4</td><td rowspan="1" colspan="1">22&#x000b7;4</td><td rowspan="1" colspan="1">55&#x000b7;0</td><td rowspan="1" colspan="1">34&#x000b7;9</td><td rowspan="1" colspan="1">74&#x000b7;1</td><td rowspan="1" colspan="1">25&#x000b7;1</td><td rowspan="1" colspan="1">71&#x000b7;3</td><td rowspan="1" colspan="1">27&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Soft</td><td rowspan="1" colspan="1">20&#x000b7;1</td><td rowspan="1" colspan="1">25&#x000b7;1</td><td rowspan="1" colspan="1">38&#x000b7;5</td><td rowspan="1" colspan="1">36&#x000b7;4</td><td rowspan="1" colspan="1">16&#x000b7;9</td><td rowspan="1" colspan="1">23&#x000b7;2</td><td rowspan="1" colspan="1">20&#x000b7;5</td><td rowspan="1" colspan="1">22&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">Abdominal pain</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;None</td><td rowspan="1" colspan="1">81&#x000b7;2</td><td rowspan="1" colspan="1">20&#x000b7;4</td><td rowspan="1" colspan="1">84&#x000b7;5</td><td rowspan="1" colspan="1">26&#x000b7;7</td><td rowspan="1" colspan="1">80&#x000b7;1</td><td rowspan="1" colspan="1">15&#x000b7;3</td><td rowspan="1" colspan="1">89&#x000b7;5</td><td rowspan="1" colspan="1">17&#x000b7;8</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Mild</td><td rowspan="1" colspan="1">15&#x000b7;2</td><td rowspan="1" colspan="1">18&#x000b7;1</td><td rowspan="1" colspan="1">12&#x000b7;4</td><td rowspan="1" colspan="1">22&#x000b7;7</td><td rowspan="1" colspan="1">16&#x000b7;2</td><td rowspan="1" colspan="1">8&#x000b7;3</td><td rowspan="1" colspan="1">7&#x000b7;2</td><td rowspan="1" colspan="1">9&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Moderate</td><td rowspan="1" colspan="1">2&#x000b7;1</td><td rowspan="1" colspan="1">15&#x000b7;2</td><td rowspan="1" colspan="1">2&#x000b7;5</td><td rowspan="1" colspan="1">11&#x000b7;7</td><td rowspan="1" colspan="1">2&#x000b7;8</td><td rowspan="1" colspan="1">4&#x000b7;1</td><td rowspan="1" colspan="1">1&#x000b7;8</td><td rowspan="1" colspan="1">5&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Severe</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">1&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;6</td><td rowspan="1" colspan="1">3&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;9</td><td rowspan="1" colspan="1">2&#x000b7;1</td><td rowspan="1" colspan="1">1&#x000b7;4</td><td rowspan="1" colspan="1">8&#x000b7;5</td></tr><tr><td rowspan="1" colspan="1">Intestinal bloating</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;None</td><td rowspan="1" colspan="1">85&#x000b7;2</td><td rowspan="1" colspan="1">18&#x000b7;2</td><td rowspan="1" colspan="1">79&#x000b7;7*&#x02020;</td><td rowspan="1" colspan="1">29&#x000b7;0</td><td rowspan="1" colspan="1">84&#x000b7;1</td><td rowspan="1" colspan="1">25&#x000b7;1</td><td rowspan="1" colspan="1">84&#x000b7;2</td><td rowspan="1" colspan="1">27&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Mild</td><td rowspan="1" colspan="1">10&#x000b7;1</td><td rowspan="1" colspan="1">11&#x000b7;8</td><td rowspan="1" colspan="1">14&#x000b7;4*&#x02020;</td><td rowspan="1" colspan="1">18&#x000b7;9</td><td rowspan="1" colspan="1">11&#x000b7;2</td><td rowspan="1" colspan="1">20&#x000b7;3</td><td rowspan="1" colspan="1">9&#x000b7;9</td><td rowspan="1" colspan="1">16&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Moderate</td><td rowspan="1" colspan="1">2&#x000b7;7</td><td rowspan="1" colspan="1">10&#x000b7;1</td><td rowspan="1" colspan="1">5&#x000b7;6*</td><td rowspan="1" colspan="1">19&#x000b7;4</td><td rowspan="1" colspan="1">2&#x000b7;5</td><td rowspan="1" colspan="1">7&#x000b7;8</td><td rowspan="1" colspan="1">4&#x000b7;8</td><td rowspan="1" colspan="1">13&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Severe</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">1&#x000b7;5</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1&#x000b7;1</td><td rowspan="1" colspan="1">4&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">Flatulence</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;None</td><td rowspan="1" colspan="1">68&#x000b7;8</td><td rowspan="1" colspan="1">32&#x000b7;6</td><td rowspan="1" colspan="1">51&#x000b7;2</td><td rowspan="1" colspan="1">38&#x000b7;9</td><td rowspan="1" colspan="1">66&#x000b7;5</td><td rowspan="1" colspan="1">30&#x000b7;1</td><td rowspan="1" colspan="1">63&#x000b7;2</td><td rowspan="1" colspan="1">37&#x000b7;5</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Mild</td><td rowspan="1" colspan="1">28&#x000b7;2</td><td rowspan="1" colspan="1">31&#x000b7;0</td><td rowspan="1" colspan="1">31&#x000b7;7</td><td rowspan="1" colspan="1">27&#x000b7;5</td><td rowspan="1" colspan="1">28&#x000b7;7</td><td rowspan="1" colspan="1">17&#x000b7;1</td><td rowspan="1" colspan="1">26&#x000b7;7</td><td rowspan="1" colspan="1">26&#x000b7;2</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Moderate</td><td rowspan="1" colspan="1">5&#x000b7;9</td><td rowspan="1" colspan="1">8&#x000b7;9</td><td rowspan="1" colspan="1">13&#x000b7;7</td><td rowspan="1" colspan="1">21&#x000b7;3</td><td rowspan="1" colspan="1">4&#x000b7;7</td><td rowspan="1" colspan="1">8&#x000b7;2</td><td rowspan="1" colspan="1">8&#x000b7;4</td><td rowspan="1" colspan="1">14&#x000b7;8</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Severe</td><td rowspan="1" colspan="1">0&#x000b7;8</td><td rowspan="1" colspan="1">2&#x000b7;3</td><td rowspan="1" colspan="1">3&#x000b7;6</td><td rowspan="1" colspan="1">9&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">5&#x000b7;7</td><td rowspan="1" colspan="1">1&#x000b7;6</td><td rowspan="1" colspan="1">5&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">Mood changes</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;Happy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;Less than normal</td><td rowspan="1" colspan="1">8&#x000b7;1</td><td rowspan="1" colspan="1">18&#x000b7;1</td><td rowspan="1" colspan="1">5&#x000b7;1</td><td rowspan="1" colspan="1">8&#x000b7;8</td><td rowspan="1" colspan="1">4&#x000b7;2</td><td rowspan="1" colspan="1">18&#x000b7;1</td><td rowspan="1" colspan="1">4&#x000b7;2</td><td rowspan="1" colspan="1">9&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;Normal</td><td rowspan="1" colspan="1">88&#x000b7;2</td><td rowspan="1" colspan="1">12&#x000b7;2</td><td rowspan="1" colspan="1">89&#x000b7;2</td><td rowspan="1" colspan="1">17&#x000b7;0</td><td rowspan="1" colspan="1">90&#x000b7;1</td><td rowspan="1" colspan="1">15&#x000b7;2</td><td rowspan="1" colspan="1">93&#x000b7;1</td><td rowspan="1" colspan="1">13&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;More than normal</td><td rowspan="1" colspan="1">2&#x000b7;0</td><td rowspan="1" colspan="1">9&#x000b7;4</td><td rowspan="1" colspan="1">6&#x000b7;8</td><td rowspan="1" colspan="1">15&#x000b7;4</td><td rowspan="1" colspan="1">6&#x000b7;4</td><td rowspan="1" colspan="1">10&#x000b7;2</td><td rowspan="1" colspan="1">2&#x000b7;7</td><td rowspan="1" colspan="1">6&#x000b7;5</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Alert</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;Less than normal</td><td rowspan="1" colspan="1">4&#x000b7;5</td><td rowspan="1" colspan="1">9&#x000b7;1</td><td rowspan="1" colspan="1">3&#x000b7;6</td><td rowspan="1" colspan="1">9&#x000b7;6</td><td rowspan="1" colspan="1">3&#x000b7;0</td><td rowspan="1" colspan="1">8&#x000b7;0</td><td rowspan="1" colspan="1">2&#x000b7;9</td><td rowspan="1" colspan="1">6&#x000b7;6</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;Normal</td><td rowspan="1" colspan="1">95&#x000b7;2</td><td rowspan="1" colspan="1">19&#x000b7;2</td><td rowspan="1" colspan="1">93&#x000b7;6</td><td rowspan="1" colspan="1">14&#x000b7;2</td><td rowspan="1" colspan="1">94&#x000b7;2</td><td rowspan="1" colspan="1">18&#x000b7;1</td><td rowspan="1" colspan="1">95&#x000b7;5</td><td rowspan="1" colspan="1">9&#x000b7;6</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;More than normal</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2&#x000b7;1</td><td rowspan="1" colspan="1">2&#x000b7;8</td><td rowspan="1" colspan="1">11&#x000b7;1</td><td rowspan="1" colspan="1">2&#x000b7;0</td><td rowspan="1" colspan="1">4&#x000b7;8</td><td rowspan="1" colspan="1">1&#x000b7;6</td><td rowspan="1" colspan="1">5&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Energetic</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;Less than normal</td><td rowspan="1" colspan="1">5&#x000b7;1</td><td rowspan="1" colspan="1">12&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;5</td><td rowspan="1" colspan="1">11&#x000b7;9</td><td rowspan="1" colspan="1">5&#x000b7;0</td><td rowspan="1" colspan="1">15&#x000b7;2</td><td rowspan="1" colspan="1">4&#x000b7;8</td><td rowspan="1" colspan="1">10&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;Normal</td><td rowspan="1" colspan="1">90&#x000b7;3</td><td rowspan="1" colspan="1">15&#x000b7;8</td><td rowspan="1" colspan="1">90&#x000b7;4</td><td rowspan="1" colspan="1">14&#x000b7;8</td><td rowspan="1" colspan="1">91&#x000b7;4</td><td rowspan="1" colspan="1">16&#x000b7;1</td><td rowspan="1" colspan="1">92&#x000b7;4</td><td rowspan="1" colspan="1">12&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;More than normal</td><td rowspan="1" colspan="1">5&#x000b7;1</td><td rowspan="1" colspan="1">7&#x000b7;6</td><td rowspan="1" colspan="1">3&#x000b7;13</td><td rowspan="1" colspan="1">8&#x000b7;74</td><td rowspan="1" colspan="1">4&#x000b7;6</td><td rowspan="1" colspan="1">6&#x000b7;0</td><td rowspan="1" colspan="1">3&#x000b7;9</td><td rowspan="1" colspan="1">7&#x000b7;6</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Stressed</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;Less than normal</td><td rowspan="1" colspan="1">3&#x000b7;2</td><td rowspan="1" colspan="1">8&#x000b7;2</td><td rowspan="1" colspan="1">4&#x000b7;01</td><td rowspan="1" colspan="1">13&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;9</td><td rowspan="1" colspan="1">2&#x000b7;8</td><td rowspan="1" colspan="1">1&#x000b7;4</td><td rowspan="1" colspan="1">4&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;Normal</td><td rowspan="1" colspan="1">89&#x000b7;1</td><td rowspan="1" colspan="1">19&#x000b7;2</td><td rowspan="1" colspan="1">90&#x000b7;10</td><td rowspan="1" colspan="1">18&#x000b7;3</td><td rowspan="1" colspan="1">96&#x000b7;1</td><td rowspan="1" colspan="1">15&#x000b7;4</td><td rowspan="1" colspan="1">94&#x000b7;6</td><td rowspan="1" colspan="1">14&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;More than normal</td><td rowspan="1" colspan="1">7&#x000b7;5</td><td rowspan="1" colspan="1">5&#x000b7;4</td><td rowspan="1" colspan="1">5&#x000b7;89</td><td rowspan="1" colspan="1">12&#x000b7;1</td><td rowspan="1" colspan="1">2&#x000b7;7</td><td rowspan="1" colspan="1">4&#x000b7;6</td><td rowspan="1" colspan="1">4&#x000b7;0</td><td rowspan="1" colspan="1">13&#x000b7;0</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>* Mean value was significantly different from that for maltodextrin
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn><fn><p>&#x02020; Mean value was significantly different from that at baseline
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn><fn><p>&#x02021; Percentage coverage of each category over the total number of responses per
volunteer was determined.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec2-5"><title>SCFA analysis</title><p>Faecal SCFA concentrations were similar following Predilife and maltodextrin
interventions (<xref ref-type="table" rid="tab04">Table 4</xref>). <table-wrap id="tab04" orientation="portrait" position="float"><label>Table 4.</label><caption><p>SCFA profiles (mmol/g faeces) determined by GC from the placebo-controlled,
double-blind, cross-over human feeding study with thirty-eight healthy human
volunteers investigating the effects of Predilife (5&#x000a0;g/d) as compared with the
placebo maltodextrin (5&#x000a0;g/d)</p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679014000688_tab4"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="4" rowspan="1">Predilife</th><th align="center" colspan="4" rowspan="1">Maltodextrin</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Baseline</th><th align="center" colspan="2" rowspan="1">Treatment</th><th align="center" colspan="2" rowspan="1">Baseline</th><th align="center" colspan="2" rowspan="1">Treatment</th></tr><tr><th align="left" rowspan="1" colspan="1">SCFA</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Acetate</td><td rowspan="1" colspan="1">0&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">Propionate</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1">Butyrate</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;5</td></tr><tr><td rowspan="1" colspan="1">Total</td><td colspan="2" rowspan="1">1&#x000b7;2</td><td colspan="2" rowspan="1">1&#x000b7;3</td><td colspan="2" rowspan="1">1&#x000b7;1</td><td colspan="2" rowspan="1">1&#x000b7;2</td></tr></tbody></table></alternatives></table-wrap></p></sec><sec id="sec2-6"><title>Faecal secretory IgA and PGE<sub>2</sub> levels</title><p>There were no significant differences in faecal sIgA concentrations or PGE<sub>2</sub>
levels when consuming Predilife or placebo (<xref ref-type="table" rid="tab05">Table
5</xref>). <table-wrap id="tab05" orientation="portrait" position="float"><label>Table 5.</label><caption><p>Changes in faecal secretory IgA (sIgA) and PGE<sub>2</sub> levels in the
placebo-controlled, double-blind, cross-over human feeding study with thirty-eight
healthy human volunteers investigating the effects of Predilife (5&#x000a0;g/d) as compared
with the placebo maltodextrin (5&#x000a0;g/d)</p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679014000688_tab5"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Baseline</th><th align="center" colspan="2" rowspan="1">Predilife treatment</th><th align="center" colspan="2" rowspan="1">Maltodextrin treatment</th></tr><tr><th align="center" rowspan="1" colspan="1">Immunological parameter</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Faecal sIgA (&#x000b5;g/g)</td><td rowspan="1" colspan="1">628&#x000b7;3</td><td rowspan="1" colspan="1">80&#x000b7;8</td><td rowspan="1" colspan="1">623&#x000b7;3</td><td rowspan="1" colspan="1">80&#x000b7;8</td><td rowspan="1" colspan="1">628&#x000b7;3</td><td rowspan="1" colspan="1">80&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">Faecal PGE<sub>2</sub> (pg/g)</td><td rowspan="1" colspan="1">1124&#x000b7;9</td><td rowspan="1" colspan="1">143&#x000b7;7</td><td rowspan="1" colspan="1">984&#x000b7;8</td><td rowspan="1" colspan="1">132&#x000b7;1</td><td rowspan="1" colspan="1">1056&#x000b7;3</td><td rowspan="1" colspan="1">89&#x000b7;3</td></tr></tbody></table></alternatives></table-wrap></p></sec><sec id="sec2-7"><title>Denaturing gradient gel electrophoresis</title><p>DGGE results demonstrated that inter-individual variability was a greater variable than
the typology of treatment. For group 1 with Predilife as the first treatment, nine of the
nineteen subject samples were clustered along the intervention. For group 2 which received
maltodextrin as the first treatment, only three of the nineteen subject samples were
grouped along the intervention. The overall fingerprint of the gut microbiota did not
differ significantly and most samples were randomly dispersed (<xref ref-type="fig" rid="fig02">Fig. 2</xref>). <fig id="fig02" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p>Cluster analysis: dendrogram of electrophoretic band pattern of subjects obtained
using universal primers in faecal samples collected at baseline (S1), and during
intake of Predilife (S2) and maltodextrin (S4).</p></caption><graphic xlink:href="S2048679014000688_fig2"/></fig></p></sec><sec id="sec2-8"><title>Microflora and SCFA changes in three-stage continuous culture models</title><p>To support the <italic>in vivo</italic> observations, we also investigated the effect of
agave fructans on the growth of faecal bacteria in a three-stage continuous culture
system. The changes in bifidobacterial and lactobacilli/enterococci populations measured
by FISH in the three vessels at the two steady states (SS1 and SS2) are shown in <xref ref-type="table" rid="tab06">Table 6</xref>. Significant increases in numbers of
<italic>Bifidobacterium</italic> spp. and
<italic>Lactobacillus</italic>/<italic>Enterococcus</italic> group were observed at SS2
in all three vessels after feeding with Synergy 1 and Predilife. No changes in bacterial
numbers were observed with maltodextrin. <table-wrap id="tab06" orientation="portrait" position="float"><label>Table 6.</label><caption><p>Bacterial enumeration using fluorescent <italic>in situ</italic> hybridisation in
the three-stage continuous system during two steady states for Predilife, Synergy 1
and maltodextrin&#x02020;</p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679014000688_tab6"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1"><italic>Bifidobacterium</italic> spp.</th><th align="center" colspan="2" rowspan="1"><italic>Lactobacillus</italic>
spp.</th></tr><tr><th align="left" rowspan="1" colspan="1">Substrate</th><th align="center" rowspan="1" colspan="1">Steady state</th><th align="center" rowspan="1" colspan="1">Vessel no.</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Predilife</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">7&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">7&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">7&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">6&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">8&#x000b7;3*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">7&#x000b7;0*</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">8&#x000b7;2*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;9*</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">7&#x000b7;8*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">6&#x000b7;7*</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Synergy 1</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">7&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">6&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">7&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">7&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">8&#x000b7;2*</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">6&#x000b7;9*</td><td rowspan="1" colspan="1">0&#x000b7;2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">8&#x000b7;2*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;8*</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">8&#x000b7;1*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;5*</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">Maltodextrin</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">7&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">6&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">7&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">7&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">7&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">6&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">7&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">7&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">6&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>* Mean value was significantly from that during steady state 1
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn><fn><p>&#x02020; Bacterial numbers were measured as log<sub>10</sub> cells/ml. Measurements were
performed on three consecutive days during each steady state (after feeding the
model with the respective substrate). Data from the 3 d were averaged.</p></fn></table-wrap-foot></table-wrap></p><p>The production of SCFA in the presence of Predilife, Synergy 1 and maltodextrin in the
three-stage continuous culture models is shown in <xref ref-type="table" rid="tab07">Table
7</xref>. Concentrations of acetate, propionate, butyrate and total fatty acids
increased significantly in all three vessels upon Predilife and Synergy 1 dosing. However,
SCFA in the presence of maltodextrin did not differ significantly. Also, no significant
differences were observed for other SCFA produced. <table-wrap id="tab07" orientation="portrait" position="float"><label>Table 7.</label><caption><p>SCFA concentrations in the three-stage continuous system during two steady states
for Predilife, Synergy 1 and maltodextrin&#x02020;</p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679014000688_tab7"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Acetic acid</th><th align="center" colspan="2" rowspan="1">Propionic acid</th><th align="center" colspan="2" rowspan="1">Butyric acid</th><th align="center" colspan="2" rowspan="1">Total SCFA</th></tr><tr><th align="left" rowspan="1" colspan="1">Substrate</th><th align="center" rowspan="1" colspan="1">Steady state</th><th align="center" rowspan="1" colspan="1">Vessel no.</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Predilife</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">1&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">1&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;00</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">31&#x000b7;8*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">10&#x000b7;2*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">7&#x000b7;1*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">49&#x000b7;1*</td><td rowspan="1" colspan="1">0&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">27&#x000b7;0*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">8&#x000b7;2*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">5&#x000b7;2*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">40&#x000b7;4*</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">12&#x000b7;5*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">12&#x000b7;5*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">4&#x000b7;2*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">28&#x000b7;2*</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">Synergy 1</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">1&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">2&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">0&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">1&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;8</td><td rowspan="1" colspan="1">3&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;8</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">28&#x000b7;5*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">12&#x000b7;8*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">5&#x000b7;9*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">47&#x000b7;9*</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">15&#x000b7;2*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">13&#x000b7;6*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">4&#x000b7;6*</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">33&#x000b7;6*</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">10&#x000b7;0*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">5&#x000b7;9*</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">2&#x000b7;8*</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">18&#x000b7;9*</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Maltodextrin</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">2&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">11&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">5&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">2&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;04</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">11&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">5&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">1&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">3&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>* Mean value was significantly from that during steady state 1
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn><fn><p>&#x02020; SCFA concentrations were measured as m<sc>m</sc>. Measurements were performed
on three consecutive days during each steady state (after feeding the model with
the respective substrate). Data from the 3 d were averaged.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec sec-type="discussion" id="sec3"><title>Discussion</title><p>This is the first randomised, cross-over, double-blind clinical trial that has examined the
effect of branched agave fructan on bacterial populations, SCFA, sIgA, PGE<sub>2</sub>,
bowel habits and mood changes in healthy human volunteers.</p><p>Agave fructans increased bifidobacteria by 0&#x000b7;4&#x000a0;log in comparison with placebo (<xref ref-type="table" rid="tab02">Table 2</xref>). The increase was similar to that observed
with other intervention studies which report increases between 0&#x000b7;5 and 1&#x000b7;0&#x000a0;log
bifidobacterial counts<sup>(</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>,</sup><xref rid="ref32" ref-type="bibr">
<sup>32&#x02013;</sup>
</xref><xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref><sup>)</sup>. In a few reports where higher bifidobacterial numbers have been
reported, higher doses of fructans were consumed<sup>(</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>,</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>)</sup>. In addition, the magnitude of change in bifidobacterial numbers also
depends on initial levels<sup>(</sup><xref rid="ref30" ref-type="bibr">
<sup>30</sup>
</xref><sup>,</sup><xref rid="ref32" ref-type="bibr">
<sup>32&#x02013;</sup>
</xref><xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref><sup>)</sup>. Bifidobacterial numbers returned to baseline levels at the end of
washout similar to previous studies<sup>(</sup><xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref><sup>,</sup><xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref><sup>,</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>&#x02013;</sup><xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref><sup>)</sup>.</p><p>In addition to the increase in bifidobacterial counts, there was an increase in the
lactobacilli/enterococci group: 0&#x000b7;4&#x000a0;log<sub>10</sub> cells/g faeces compared with placebo
(<xref ref-type="table" rid="tab02">Table 2</xref>). This is similar to previous reports
with fructans from chicory<sup>(</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>)</sup> and globe artichoke<sup>(</sup><xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref><sup>)</sup> where increases in lactobacilli/enterococci have been observed. There
have been a few reports with fructans from Jerusalem artichoke<sup>(</sup><xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref><sup>,</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>)</sup> or chicory<sup>(</sup><xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref><sup>)</sup> where either no or less change in the lactobacilli/enterococci group has
been reported.</p><p>There was no change in the numbers of total bacteria, <italic>Atopobium</italic>,
<italic>Bacteroides</italic>, <italic>Eubacterium rectale</italic>/<italic>Clostridium
coccoides</italic>, <italic>E. coli</italic> and
<italic>Roseburia</italic>/<italic>Eubacteria</italic> group. This contrasts with
decreases in levels of <italic>Bacteroides</italic> and clostridia reported in other studies
with globe artichoke and Jerusalem artichoke inulin<sup>(</sup><xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref><sup>,</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>)</sup>. Overall, there were no significant differences in faecal SCFA
concentrations. It is recognised that over 95 % of SCFA produced in the human large
intestine is absorbed, with only a small proportion is excreted in faeces<sup>(</sup><xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref><sup>&#x02013;</sup><xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref><sup>,</sup><xref rid="ref39" ref-type="bibr">
<sup>39</sup>
</xref><sup>)</sup>.</p><p>Parallel to the human trial, the dynamics of bacterial growth and fermentation induced in
the presence of Predilife was assessed and compared with Synergy 1 and maltodextrin using a
three-stage continuous culture models. Both agave- and chicory-derived inulin stimulated the
growth of bifidobacteria and lactobacilli to a similar extent (0&#x000b7;4&#x02013;0&#x000b7;6&#x000a0;log<sub>10</sub>
cells/ml) as with the human trial data. However, the SCFA data indicated an increased
production of acetate, propionate and butyrate, which contrasted with the human study data.
This presumably reflected the fact that SCFA were rapidly absorbed by the human
colon<sup>(</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>)</sup>. It may also suggest that the fructans were rapidly fermented in the
proximal colon and thus not excreted in the faeces<sup>(</sup><xref rid="ref40" ref-type="bibr">
<sup>40</sup>
</xref><sup>)</sup>. Further, the bacterial groups that were active agave degraders do not
produce butyrate. This can be explained by substantial information on cross-feeding of
fermentation products by gut microbiota<sup>(</sup><xref rid="ref41" ref-type="bibr">
<sup>41</sup>
</xref><sup>,</sup><xref rid="ref42" ref-type="bibr">
<sup>42</sup>
</xref><sup>)</sup>. The results from the <italic>in vivo</italic> and <italic>in
vitro</italic> trials with branched agave fructans were consistent with those for linear
fructans<sup>(</sup><xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref><sup>,</sup><xref rid="ref32" ref-type="bibr">
<sup>32&#x02013;</sup>
</xref><xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref><sup>)</sup>. This indicates that structural differences between linear inulin type
(&#x003b2;2-1 linkages) and branched agave (&#x003b2;2-1; 2-6 linkages) fructans do not seem to influence
modulation of gut microbiota or their fermentation profiles.</p><p>As the extent of fermentation is also influenced by the degree of polymerisation, it may be
suggested that the lower chain lengths in Predilife (degree of polymerisation
3&#x02013;30)<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>)</sup> may contribute to the prebiotic effect. Further investigation of the
fractions of agave fructans to identify chain lengths responsible for these effects may be
warranted.</p><p>The effect of Predilife consumption on bowel habits and quality of life of subjects was
assessed during the trial. Predilife did not influence the measured aspects of quality of
life: mood, alertness, energy and stress levels. However, effects on bowel habits were more
profound. No significant changes in stool frequency or consistencies were observed. There
was no significant increase in abdominal pain levels. However, significantly increased
intestinal bloating (mild to moderate) and flatulence (mild and severe) were recorded by
subjects when consuming Predilife. Several studies have reported stimulation of bowel
movements, and increased bloating and flatulence on ingestion of fructans<sup>(</sup><xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref><sup>,</sup><xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref><sup>,</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>,</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>,</sup><xref rid="ref39" ref-type="bibr">
<sup>39</sup>
</xref><sup>,</sup><xref rid="ref43" ref-type="bibr">
<sup>43</sup>
</xref><sup>,</sup><xref rid="ref44" ref-type="bibr">
<sup>44</sup>
</xref><sup>)</sup>. The formation of H<sub>2</sub>, which is a metabolic endproduct of
bacterial fermentation in the colon, is a major cause of flatulence. However, it must be
noted that bifidobacteria, the numbers of which were significantly increased on intake of
Predilife, are not considered to be producers of H<sub>2</sub>, or any other gas. In
contrast, clostridia are prolific gas producers, but did not show any significant increase
upon ingestion of Predilife. Thus, the relationship between specific intestinal bacteria and
gas production remains to be clarified<sup>(</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>,</sup><xref rid="ref45" ref-type="bibr">
<sup>45</sup>
</xref><sup>)</sup>.</p><p>The effect of Predilife consumption on the faecal immune markers sIgA and PGE<sub>2</sub>
was also determined. No change in these markers was observed. Faecal sIgA is primarily
involved in mucosal immunity and protein barrier function against infection<sup>(</sup><xref rid="ref46" ref-type="bibr">
<sup>46</sup>
</xref><sup>)</sup>. PGE<sub>2</sub> plays a role in immune modulation and normal
physiological gastrointestinal functions including cytoprotection<sup>(</sup><xref rid="ref47" ref-type="bibr">
<sup>47</sup>
</xref><sup>)</sup>. In previous studies with pre- and probiotics, increases in immune
markers<sup>(</sup><xref rid="ref46" ref-type="bibr">
<sup>46</sup>
</xref><sup>,</sup><xref rid="ref47" ref-type="bibr">
<sup>47</sup>
</xref><sup>)</sup>, unchanged levels<sup>(</sup><xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref><sup>,</sup><xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref><sup>,</sup><xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref><sup>)</sup> and decreased levels have been reported<sup>(</sup><xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref><sup>,</sup><xref rid="ref50" ref-type="bibr">
<sup>50</sup>
</xref><sup>)</sup>. Many factors including stress, exercise and dietary fat may have an
impact on these immune parameters<sup>(</sup><xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref><sup>,</sup><xref rid="ref51" ref-type="bibr">
<sup>51</sup>
</xref><sup>,</sup><xref rid="ref52" ref-type="bibr">
<sup>52</sup>
</xref><sup>)</sup>, therefore resulting in variable trends. DGGE analyses, which allow a
semi-qualitative evaluation of the fingerprint of the gut microbiota of subjects enrolled in
the study, indicated that the treatment did not significantly modify the overall fingerprint
of the gut microbiota to a great extent (to overcome the inter-individual differences). No
significant differences were indicated between Predilife and maltodextrin.</p><p>In conclusion, <italic>in vivo</italic> and <italic>in vitro</italic> data confirm the
prebiotic effectiveness of agave fructans as observed by selective increases in
bifidobacteria and lactobacilli populations. Agave represents an important alternative
prebiotic to other sources of fructans. In addition, due to its good solubility in cold
water, it can be readily incorporated into beverages, dairy products, cheese and
yogurts.</p></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Dr Anne McCartney for help with DGGE gels.</p><p>We thank the Sensory Dimensions, Science and Technology Centre for distributing recruitment
letters to volunteers and Ms Jan Luff of the Hugh Sinclair Unit, Department of Food and
Nutrition Sciences for help with recruitment. We are grateful to all volunteers who
participated in the study.</p><p>The present study was financially supported by Bustar Alimetos, SAGARPA and COFUPRO,
Mexico.</p><p>P. R. wrote the manuscript, carried out the trial and performed experimental analysis. A.
C. performed DGGE analysis and contributed to the manuscript. B. A. G. R. provided the
products and contributed to the design of the study and preparation of the manuscript. G. R.
G. designed the study and contributed to the preparation of the manuscript.</p><p>There were no conflicts of interest among the authors.</p></ack><ref-list id="reflist1"><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="book"><name><surname>Gibson</surname><given-names>GR</given-names></name> &#x00026; <name><surname>Roberfroid</surname><given-names>MB</given-names></name> (editors) (<year>1999</year>) <source>Colonic Microbiota, Nutrition and
Health</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Kluwer Academic
Publishers</publisher-name>.</mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Steer</surname><given-names>T</given-names></name>, <name><surname>Carpenter</surname><given-names>H</given-names></name>, <name><surname>Tuohy</surname><given-names>K</given-names></name>, <etal/> (<year>2001</year>) <article-title>Perspectives on the role of the human
gut microbiota in health and disease and its modulation by pro- and
prebiotics</article-title>. <source>Nutr Res Rev</source>
<volume>13</volume>, <fpage>229</fpage>&#x02013;<lpage>254</lpage>.<pub-id pub-id-type="pmid">19087441</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Kolida</surname><given-names>S</given-names></name> &#x00026; <name><surname>Gibson</surname><given-names>GR</given-names></name> (<year>2007</year>) <article-title>Prebiotic capacity of inulin type
fructans</article-title>. <source>J Nutr</source>
<volume>137</volume>, <fpage>2503S</fpage>&#x02013;<lpage>2506S</lpage>.<pub-id pub-id-type="pmid">17951493</pub-id></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Fuller</surname><given-names>R</given-names></name> &#x00026; <name><surname>Gibson</surname><given-names>GR</given-names></name> (<year>1997</year>) <article-title>Modification of the intestinal microflora using
probiotics and prebiotics</article-title>. <source>Scan J Gastroenterol</source>
<volume>32</volume>, <fpage>28</fpage>&#x02013;<lpage>31</lpage>.</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Gibson</surname><given-names>GR</given-names></name>, <name><surname>Scott</surname><given-names>KP</given-names></name>, <name><surname>Rastall</surname><given-names>RA</given-names></name>, <etal/> (<year>2010</year>) <article-title>Dietary prebiotics: current status and
new definition</article-title>. <source>IFIS Bull</source>
<volume>7</volume>, <fpage>1</fpage>&#x02013;<lpage>19</lpage>.</mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Hobden</surname><given-names>MR</given-names></name>, <name><surname>Martin-Morales</surname><given-names>A</given-names></name>, <name><surname>Gu&#x000e9;rin-Deremaux</surname><given-names>L</given-names></name>, <etal/> (<year>2013</year>) <article-title><italic>In vitro</italic> fermentation
of NUTRIOSE&#x000ae; FB06, a wheat dextrin soluble fibre in a continuous human colonic model
system</article-title>. <source>PLOS ONE</source>
<volume>8</volume>, <elocation-id>e10</elocation-id>.</mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Roberfroid</surname><given-names>MB</given-names></name> (<year>2005</year>) <article-title>Introducing inulin-type
fructans</article-title>. <source>Br J Nutr</source>
<volume>93</volume>, <fpage>S13</fpage>&#x02013;<lpage>S25</lpage>.<pub-id pub-id-type="pmid">15877886</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Mojica</surname><given-names>EM</given-names></name> &#x00026; <name><surname>Lopez</surname><given-names>MG</given-names></name> (<year>2012</year>) <article-title>Fructan metabolism in <italic>A
tequilana</italic> Weber blue variety along its developmental cycle in the
field</article-title>. <source>J Agric Food Chem</source>
<volume>60</volume>, <fpage>11704</fpage>&#x02013;<lpage>11713</lpage>.<pub-id pub-id-type="pmid">23072425</pub-id></mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Slaven</surname><given-names>J</given-names></name> (<year>2013</year>) <article-title>Fiber and prebiotics: mechanisms and health
benefits</article-title>. <source>Nutrients</source>
<volume>5</volume>, <fpage>1417</fpage>&#x02013;<lpage>1435</lpage>.<pub-id pub-id-type="pmid">23609775</pub-id></mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Meyer</surname><given-names>D</given-names></name> &#x00026; <name><surname>Stasse</surname><given-names>WM</given-names></name> (<year>2009</year>) <article-title>The bifidogenic effect of inulin and
oligofructose and its consequences for gut health</article-title>. <source>Eur J Clin
Nutr</source>
<volume>63</volume>, <fpage>1277</fpage>&#x02013;<lpage>1289</lpage>.<pub-id pub-id-type="pmid">19690573</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Kelly</surname><given-names>G</given-names></name> (<year>2009</year>) <article-title>Inulin-type prebiotics: a review (part
2)</article-title>. <source>Alt Med Rev</source>
<volume>14</volume>, <fpage>36</fpage>&#x02013;<lpage>55</lpage>.</mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Biedrzycka</surname><given-names>E</given-names></name> &#x00026; <name><surname>Bielecka</surname><given-names>M</given-names></name> (<year>2004</year>) <article-title>Prebiotic effectiveness of fructans of
different degrees of polymerisation</article-title>. <source>Trends Food Sci Technol</source>
<volume>15</volume>, <fpage>170</fpage>&#x02013;<lpage>175</lpage>.</mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Van Loo</surname><given-names>J</given-names></name> (<year>2004</year>) <article-title>The specificity of the interaction with
intestinal bacterial fermentation by prebiotics determines their prebiotic
efficacy</article-title>. <source>Nutr Res Rev</source>
<volume>17</volume>, <fpage>89</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">19079918</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Van de Wiele</surname><given-names>T</given-names></name>, <name><surname>Boon</surname><given-names>N</given-names></name>, <name><surname>Possemiers</surname><given-names>S</given-names></name>, <etal/> (<year>2007</year>) <article-title>Inulin type fructans of longer degree
of polymerisation exert more pronounced <italic>in vitro</italic> prebiotic
effects</article-title>. <source>J Appl Microbiol</source>
<volume>102</volume>, <fpage>452</fpage>&#x02013;<lpage>460</lpage>.<pub-id pub-id-type="pmid">17241351</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Gomez</surname><given-names>E</given-names></name>, <name><surname>Tuohy</surname><given-names>KM</given-names></name>, <name><surname>Gibson</surname><given-names>GR</given-names></name>, <etal/> (<year>2010</year>) <article-title><italic>In vitro</italic> evaluation
of the fermentation properties and potential prebiotic activity of agave
fructans</article-title>. <source>J Appl Microbiol</source>
<volume>108</volume>, <fpage>2114</fpage>&#x02013;<lpage>2121</lpage>.<pub-id pub-id-type="pmid">19941629</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Lopez</surname><given-names>MG</given-names></name>, <name><surname>Mancilla-Margalli</surname><given-names>NA</given-names></name> &#x00026; <name><surname>Mendoza-Diaz</surname><given-names>G</given-names></name> (<year>2003</year>) <article-title>Molecular structures of fructans from
<italic>Agave tequilana</italic> Weber var. <italic>azul</italic></article-title>.
<source>J Agric Food Chem</source>
<volume>S1</volume>, <fpage>7835</fpage>&#x02013;<lpage>7840</lpage>.<pub-id pub-id-type="pmid">14690361</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Mancilla-Margalli</surname><given-names>NA</given-names></name> &#x00026; <name><surname>Lopez</surname><given-names>MG</given-names></name> (<year>2006</year>) <article-title>Water soluble carbohydrates and fructan
structures patterns from <italic>Agave</italic> and <italic>Dasylirion</italic>
species</article-title>. <source>J Agric Food Chem</source>
<volume>54</volume>, <fpage>7832</fpage>&#x02013;<lpage>7839</lpage>.<pub-id pub-id-type="pmid">17002459</pub-id></mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Vulevic</surname><given-names>J</given-names></name>, <name><surname>Drakoularakou</surname><given-names>A</given-names></name>, <name><surname>Yaqoob</surname><given-names>P</given-names></name>, <etal/> (<year>2008</year>) <article-title>Modulation of the fecal microflora
profile and immune function by a novel <italic>trans</italic>-galactooligosaccharide
mixture (B-GOS) in healthy elderly volunteers</article-title>. <source>Am J Clin Nutr</source>
<volume>88</volume>, <fpage>1438</fpage>&#x02013;<lpage>1446</lpage>.<pub-id pub-id-type="pmid">18996881</pub-id></mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Costabile</surname><given-names>A</given-names></name>, <name><surname>Fava</surname><given-names>F</given-names></name>, <name><surname>Roytio</surname><given-names>H</given-names></name>, <etal/> (<year>2012</year>) <article-title>Impact of polydextrose on the faecal
microbiota: a double blind crossover, placebo-controlled feeding study in healthy human
subjects</article-title>. <source>Br J Nutr</source>
<volume>108</volume>, <fpage>471</fpage>&#x02013;<lpage>481</lpage>.<pub-id pub-id-type="pmid">22099384</pub-id></mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Langendijk</surname><given-names>PS</given-names></name>, <name><surname>Schut</surname><given-names>F</given-names></name>, <name><surname>Jansen</surname><given-names>GJ</given-names></name>, <etal/> (<year>1995</year>) <article-title>Quantitative fluorescent <italic>in
situ</italic> hybridisation of <italic>Bifidobacterium</italic> spp. with genus
specific 16S rRNA targeted probes and its application in faecal samples</article-title>.
<source>Appl Environ Microbiol</source>
<volume>61</volume>, <fpage>3069</fpage>&#x02013;<lpage>3075</lpage>.<pub-id pub-id-type="pmid">7487040</pub-id></mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Harmsen</surname><given-names>HJM</given-names></name>, <name><surname>Elfferich</surname><given-names>P</given-names></name>, <name><surname>Schut</surname></name>, <etal/> (<year>1999</year>) <article-title>A 16S rRNA targeted probe for
detection of lactobacilli and enterococci in faecal samples by fluorescent <italic>in
situ</italic> hybridisation</article-title>. <source>Microb Ecol Health Dis</source>
<volume>11</volume>, <fpage>3</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Franks</surname><given-names>AH</given-names></name>, <name><surname>Harmsen</surname><given-names>HJ</given-names></name>, <name><surname>Raangs</surname><given-names>GC</given-names></name>, <etal/> (<year>1998</year>) <article-title>Variations of bacterial populations in
human faeces measured by fluorescent <italic>in situ</italic> hybridisation with group
specific 16S rRNA targeted oligonucleotide probes</article-title>. <source>Appl Environ
Microbiol</source>
<volume>64</volume>, <fpage>3336</fpage>&#x02013;<lpage>3345</lpage>.<pub-id pub-id-type="pmid">9726880</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Harmsen</surname><given-names>HJ</given-names></name>, <name><surname>WildeboerVeloo</surname><given-names>ACM</given-names></name>, <name><surname>Grijpstra</surname><given-names>J</given-names></name>, <etal/> (<year>2000</year>) <article-title>Development of 16S rRNA based probes
for the <italic>Coribacterium</italic> group and the <italic>Atopobium</italic> cluster
and their application for enumeration of Coriobacteriaceae in human faeces from
volunteers of different ages</article-title>. <source>Appl Environ Microbiol</source>
<volume>66</volume>, <fpage>4523</fpage>&#x02013;<lpage>4527</lpage>.<pub-id pub-id-type="pmid">11010909</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Manz</surname><given-names>W</given-names></name>, <name><surname>Amann</surname><given-names>R</given-names></name>, <name><surname>Ludwig</surname><given-names>W</given-names></name>, <etal/> (<year>1996</year>) <article-title>Application of a suite of 16S rRNA
specific oligonucleotide probes designed to investigate bacteria of the phylum
cytophaga-flavobacter-<italic>Bacteroides</italic> in the natural
environment</article-title>. <source>Microbiology</source>
<volume>142</volume>, <fpage>1097</fpage>&#x02013;<lpage>1106</lpage>.<pub-id pub-id-type="pmid">8704951</pub-id></mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Poulsen</surname><given-names>LK</given-names></name>, <name><surname>Lan</surname><given-names>F</given-names></name>, <name><surname>Kristensen</surname><given-names>CS</given-names></name>, <etal/> (<year>1994</year>) <article-title>Spatial distribution of
<italic>Escherichia coli</italic> in the mouse large intestine inferred from rRNA
<italic>in situ</italic> hybridisation</article-title>. <source>Infect Immun</source>
<volume>62</volume>, <fpage>5191</fpage>&#x02013;<lpage>5194</lpage>.<pub-id pub-id-type="pmid">7927805</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Daims</surname><given-names>H</given-names></name>, <name><surname>Bruhl</surname><given-names>A</given-names></name>, <name><surname>Amann</surname><given-names>R</given-names></name>, <etal/> (<year>1999</year>) <article-title>The domain specific probe EUB 338 is
insufficient for the detection of all bacteria: development and evaluation of a more
comprehensive probe set</article-title>. <source>Syst Appl Microbiol</source>
<volume>22</volume>, <fpage>434</fpage>&#x02013;<lpage>444</lpage>.<pub-id pub-id-type="pmid">10553296</pub-id></mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Richardson</surname><given-names>AJ</given-names></name>, <name><surname>Calder</surname><given-names>AG</given-names></name>, <name><surname>Schleifer</surname><given-names>KH</given-names></name>, <etal/> (<year>1989</year>) <article-title>Simultaneous determination of volatile
and non-volatile acid fermentation products of anaerobes by capillary gas
chromatography</article-title>. <source>Lett Appl Microbiol</source>
<volume>9</volume>, <fpage>5</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Muyzer</surname><given-names>G</given-names></name>, <name><surname>de Waal</surname><given-names>EC</given-names></name> &#x00026; <name><surname>Uitterlinden</surname><given-names>AG</given-names></name> (<year>1993</year>) <article-title>Profiling of complex microbial populations by
denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified
genes coding for 16S rRNA</article-title>. <source>Appl Env Microbiol</source>
<volume>59</volume>, <fpage>695</fpage>&#x02013;<lpage>700</lpage>.<pub-id pub-id-type="pmid">7683183</pub-id></mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Macfarlane</surname><given-names>GT</given-names></name>, <name><surname>Macfarlane</surname><given-names>S</given-names></name> &#x00026; <name><surname>Gibson</surname><given-names>GR</given-names></name> (<year>1998</year>) <article-title>Validation of a three-stage compound continuous
culture system for investigating the effect of retention time on the ecology and SCFA
metabolism of bacteria in the human colon</article-title>. <source>Microb Ecol</source>
<volume>35</volume>, <fpage>180</fpage>&#x02013;<lpage>187</lpage>.<pub-id pub-id-type="pmid">9541554</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Kolida</surname><given-names>S</given-names></name>, <name><surname>Meyer</surname><given-names>D</given-names></name> &#x00026; <name><surname>Gibson</surname><given-names>GR</given-names></name> (<year>2007</year>) <article-title>A double blind placebo controlled study to
establish the bifidogenic dose of inulin in healthy humans</article-title>. <source>Eur
J ClinNutr</source>
<volume>61</volume>, <fpage>1189</fpage>&#x02013;<lpage>1195</lpage>.</mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Costabile</surname><given-names>A</given-names></name>, <name><surname>Klinder</surname><given-names>A</given-names></name>, <name><surname>Fava</surname><given-names>F</given-names></name>, <etal/> (<year>2008</year>) <article-title>Whole grain wheat breakfast cereal has
a prebiotic effect on the human gut microbiota: a double blind, placebo controlled,
cross-over study</article-title>. <source>Br J Nutr</source>
<volume>99</volume>, <fpage>110</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">17761020</pub-id></mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Costabile</surname><given-names>A</given-names></name>, <name><surname>Kolida</surname><given-names>S</given-names></name>, <name><surname>Klinder</surname><given-names>A</given-names></name>, <etal/> (<year>2010</year>) <article-title>A double blind placebo controlled
study to establish the bifidogenic effect of a very long chain inulin extracted from
globe artichoke (<italic>Cynarascolymus</italic>) in healthy human
subjects</article-title>. <source>Br J Nutr</source>
<volume>104</volume>, <fpage>1007</fpage>&#x02013;<lpage>1017</lpage>.<pub-id pub-id-type="pmid">20591206</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Ramnani</surname><given-names>P</given-names></name>, <name><surname>Gaudier</surname><given-names>E</given-names></name>, <name><surname>Bingham</surname><given-names>M</given-names></name>, <etal/> (<year>2010</year>) <article-title>Prebiotic effect of fruit and
vegetable shots containing Jerusalem artichoke inulin: a human intervention
study</article-title>. <source>Br J Nutr</source>
<volume>104</volume>, <fpage>233</fpage>&#x02013;<lpage>240</lpage>.<pub-id pub-id-type="pmid">20187995</pub-id></mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Tuohy</surname><given-names>KM</given-names></name>, <name><surname>Kolida</surname><given-names>S</given-names></name>, <name><surname>Lustenberger</surname><given-names>A</given-names></name>, <etal/> (<year>2001</year>) <article-title>The prebiotic effects of biscuits
containing partially hydrolysed guar gum and fructooligosaccharides &#x02013; a human volunteer
study</article-title>. <source>Br J Nutr</source>
<volume>86</volume>, <fpage>341</fpage>&#x02013;<lpage>348</lpage>.<pub-id pub-id-type="pmid">11570986</pub-id></mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Kleessen</surname><given-names>B</given-names></name>, <name><surname>Schwarz</surname><given-names>S</given-names></name>, <name><surname>Boehm</surname><given-names>A</given-names></name>, <etal/> (<year>2007</year>) <article-title>Jerusalem artichoke and chicory inulin
in bakery products affect faecal microbiota of healthy volunteers</article-title>.
<source>Br J Nutr</source>
<volume>98</volume>, <fpage>540</fpage>&#x02013;<lpage>549</lpage>.<pub-id pub-id-type="pmid">17445348</pub-id></mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Kruse</surname><given-names>HP</given-names></name>, <name><surname>Kleesen</surname><given-names>B</given-names></name> &#x00026; <name><surname>Blaut</surname><given-names>M</given-names></name> (<year>1999</year>) <article-title>Effects of inulin on faecal bifidobacteria in
human subjects</article-title>. <source>Br J Nutr</source>
<volume>82</volume>, <fpage>375</fpage>&#x02013;<lpage>382</lpage>.<pub-id pub-id-type="pmid">10673910</pub-id></mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Tuohy</surname><given-names>KM</given-names></name>, <name><surname>Finlay</surname><given-names>RK</given-names></name>, <name><surname>Wynne</surname><given-names>AG</given-names></name>, <etal/> (<year>2001</year>) <article-title>A human volunteer study on the
prebiotic effects of HP-inulin &#x02013; faecal bacteria enumerated using fluorescent <italic>in
situ</italic> hybridisation (FISH)</article-title>. <source>Anaerobe</source>
<volume>7</volume>, <fpage>113</fpage>&#x02013;<lpage>118</lpage>.</mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Gibson</surname><given-names>GR</given-names></name>, <name><surname>Beatty</surname><given-names>ER</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <etal/> (<year>1995</year>) <article-title>Selective stimulation of
bifidobacteria in human colon by oligofructose and inulin</article-title>.
<source>Gastroenterology</source>
<volume>108</volume>, <fpage>975</fpage>&#x02013;<lpage>982</lpage>.<pub-id pub-id-type="pmid">7698613</pub-id></mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Coussement</surname><given-names>P</given-names></name> (<year>1999</year>) <article-title>Inulin and oligofructose: safe intakes and
legal status</article-title>. <source>J Nutr</source>
<volume>129</volume>, <fpage>1412S</fpage>&#x02013;<lpage>1417S</lpage>.<pub-id pub-id-type="pmid">10395609</pub-id></mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="book"><name><surname>Gibson</surname><given-names>GR</given-names></name> &#x00026; <name><surname>Rastall</surname><given-names>RA</given-names></name> (<year>2006</year>) <source>Prebiotics: Development and Application</source>.
<publisher-loc>Chichester</publisher-loc>: <publisher-name>John Wiley &#x00026;
Sons</publisher-name>.</mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Belenguer</surname><given-names>A</given-names></name>, <name><surname>Duncan</surname><given-names>SH</given-names></name>, <name><surname>Calder</surname><given-names>G</given-names></name>, <etal/> (<year>2006</year>) <article-title>Two routes of metabolic cross-feeding
between <italic>Bifidobacterium adolescentis</italic> and butyrate producing anaerobes
from the human gut</article-title>. <source>Appl Eviron Microbiol</source>
<volume>72</volume>, <fpage>3593</fpage>&#x02013;<lpage>3599</lpage>.</mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Flint</surname><given-names>HJ</given-names></name> (<year>2012</year>) <article-title>The impact of diet on the human
microbiome</article-title>. <source>Nutr Rev</source>
<volume>70</volume>, <fpage>S10</fpage>&#x02013;<lpage>S13</lpage>.<pub-id pub-id-type="pmid">22861801</pub-id></mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Mortensen</surname><given-names>PB</given-names></name>, <name><surname>Clausen</surname><given-names>MR</given-names></name>, <name><surname>Bonnen</surname><given-names>H</given-names></name>, <etal/> (<year>1992</year>) <article-title>Colonic fermentation of ispaghula,
whean bran, glucose and albumin to short chain fatty acids and ammonia evaluated
<italic>in vitro</italic> in 50 subjects</article-title>. <source>JPEN J Parenter
Enteral Nutr</source>
<volume>16</volume>, <fpage>433</fpage>&#x02013;<lpage>439</lpage>.<pub-id pub-id-type="pmid">1331553</pub-id></mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>De Hond</surname><given-names>E</given-names></name>, <name><surname>Geypens</surname><given-names>B</given-names></name> &#x00026; <name><surname>Ghoos</surname><given-names>Y</given-names></name> (<year>2000</year>) <article-title>Effect of high performance chicory inulin on
constipation</article-title>. <source>Nutr Res</source>
<volume>20</volume>, <fpage>731</fpage>&#x02013;<lpage>736</lpage>.</mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Probert</surname><given-names>HM</given-names></name>, <name><surname>Apajalhati</surname><given-names>JHA</given-names></name>, <name><surname>Rautonen</surname><given-names>N</given-names></name>, <etal/> (<year>2004</year>) <article-title>Polydextrose, lactitol, and
fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous
culture system</article-title>. <source>Appl Environ Microbiol</source>
<volume>70</volume>, <fpage>4505</fpage>&#x02013;<lpage>4511</lpage>.<pub-id pub-id-type="pmid">15294779</pub-id></mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>Vulevic</surname><given-names>J</given-names></name>, <name><surname>Juric</surname><given-names>A</given-names></name>, <name><surname>Tzortzis</surname><given-names>G</given-names></name>, <etal/> (<year>2013</year>) <article-title>A mixture of
<italic>trans</italic>-galactooligosaccharides reduces markers of metabolic syndrome and
modulates faecal microbiota and immune function of overweight adults</article-title>.
<source>J Nutr</source>
<volume>143</volume>, <fpage>324</fpage>&#x02013;<lpage>331</lpage>.<pub-id pub-id-type="pmid">23303873</pub-id></mixed-citation></ref><ref id="ref47"><label>47.</label><mixed-citation publication-type="journal"><name><surname>Ouwehand</surname><given-names>AC</given-names></name>, <name><surname>Tiihonen</surname><given-names>K</given-names></name>, <name><surname>Saarinen</surname><given-names>M</given-names></name>, <etal/> (<year>2009</year>) <article-title>Influence of a combination of
<italic>Lactobacillus acidophilus</italic> NCFM and lactitol on healthy elderly:
intestinal and immune parameters</article-title>. <source>Br J Nutr</source>
<volume>101</volume>, <fpage>367</fpage>&#x02013;<lpage>375</lpage>.<pub-id pub-id-type="pmid">18634707</pub-id></mixed-citation></ref><ref id="ref48"><label>48.</label><mixed-citation publication-type="journal"><name><surname>Lahtinen</surname><given-names>SJ</given-names></name>, <name><surname>Forssten</surname><given-names>S</given-names></name>, <name><surname>Aakko</surname><given-names>J</given-names></name>, <etal/> (<year>2012</year>) <article-title>Probiotic cheese containing
<italic>Lactobacillus rhamnsosus</italic> HN001 and <italic>Lactobacillus
acidophilus</italic> NCFM&#x000ae; modifies subpopulations of faecal lactobacilli and
<italic>Clostridium difficile</italic> in the elderly</article-title>. <source>Age</source>
<volume>34</volume>, <fpage>133</fpage>&#x02013;<lpage>143</lpage>.<pub-id pub-id-type="pmid">21264685</pub-id></mixed-citation></ref><ref id="ref49"><label>49.</label><mixed-citation publication-type="journal"><name><surname>Hafer</surname><given-names>A</given-names></name>, <name><surname>Kr&#x000e4;mer</surname><given-names>S</given-names></name>, <name><surname>Duncker</surname><given-names>S</given-names></name>, <etal/> (<year>2007</year>) <article-title>Effects of oral lactulose on clinical
and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot
study</article-title>. <source>BMC Gastroenetrol</source>
<volume>7</volume>, <fpage>36</fpage>.</mixed-citation></ref><ref id="ref50"><label>50.</label><mixed-citation publication-type="journal"><name><surname>Tiihonen</surname><given-names>K</given-names></name>, <name><surname>Suomalainen</surname><given-names>T</given-names></name>, <name><surname>Tynkkynen</surname><given-names>S</given-names></name>, <etal/> (<year>2008</year>) <article-title>Effect of prebiotic supplementation on
a probiotic bacteria mixture: composition between a rat model and clinical
trials</article-title>. <source>Br J Nutr</source>
<volume>99</volume>, <fpage>826</fpage>&#x02013;<lpage>831</lpage>.<pub-id pub-id-type="pmid">17868490</pub-id></mixed-citation></ref><ref id="ref51"><label>51.</label><mixed-citation publication-type="journal"><name><surname>Myles</surname><given-names>IA</given-names></name>, <name><surname>Fntecilla</surname><given-names>NM</given-names></name>, <name><surname>Janelsins</surname><given-names>BM</given-names></name>, <etal/> (<year>2013</year>) <article-title>Parental dietary fat intake alters
offspring microbiome and immunity</article-title>. <source>J Immunol</source>
<volume>191</volume>, <fpage>3200</fpage>&#x02013;<lpage>3209</lpage>.<pub-id pub-id-type="pmid">23935191</pub-id></mixed-citation></ref><ref id="ref52"><label>52.</label><mixed-citation publication-type="journal"><name><surname>Walton</surname><given-names>GE</given-names></name>, <name><surname>Lu</surname><given-names>C</given-names></name>, <name><surname>Trough</surname><given-names>I</given-names></name>, <etal/> (<year>2012</year>) <article-title>A randomised, double blind, placebo
controlled cross-over study to determine the gastrointestinal effects of consumption of
arabinoxylan oligosaccharide enriched bread in healthy volunteers</article-title>.
<source>Nutr J</source>
<volume>11</volume>, <fpage>36</fpage>.<pub-id pub-id-type="pmid">22657950</pub-id></mixed-citation></ref></ref-list></back></article>